🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Adenocarcinoma Resectable

CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) NCT04926467Phase 21 site📍 Dallas Baylor Research Institute · Tests: Anakinra Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer NCT04969731Phase 31 site📍 Seoul GC Cell Corporation · Tests: Immuncell-LC, Gemcitabine Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula NCT05116072Phase 1, Phase 21 site📍 Lille University Hospital, Lille · Tests: total pancreatectomy, intraportal islet autotransplantation Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma NCT04998552NA1 site📍 Pennington Capital Health System, Inc · Tests: Cyberknife DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer NCT07705919Phase 1, Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Computed Tomography, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Fluorouracil, Gadoli… Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC NCT06714604Phase 31 site📍 Gothenburg Sahlgrenska University Hospital · Tests: FOLFIRINOX or gemcitabine-nab-paclitaxel, FOLFIRINOX or gemcitabine-nab-paclitaxel Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) NCT06384560Phase 1, Phase 24 sites📍 Amsterdam📍 Maastricht📍 Nieuwegein Amsterdam UMC, location VUmc · Tests: Pembrolizumab, Folfirinox, SABR Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: Genetic testing, Optional biopsy, Tissue collection Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma NCT06582017Phase 111 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles Nammi Therapeutics Inc · Tests: QXL138AM Injection every 2 weeks by IV Infusion Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma NCT05688215Phase 1, Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biospecimen Collection, Computed Tomography, Core Biopsy, Fluorouracil, Irinotecan Adjuvant Pancreatic Therapy Guided by MRD NCT06966440NA1 site📍 Shanghai Ruijin Hospital · Tests: circulating tumor DNA (ctDNA)-based MRD, adjuvant chemotherapy regimens Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932Phase 1, Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: AGEN2373, Balstilimab, Cyclophosphamide, GVAX, AGEN2373 (RP2D) Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer NCT03492671Phase 21 site📍 Loma Linda Loma Linda University · Tests: Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic Body Radiation Therapy A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer NCT07481383Phase 12 sites📍 Ann Arbor📍 Morgantown Continuity Biosciences, LLC · Tests: ACT Implantable Iontophoresis Chemotherapy Delivery Device with Gemcitabine (ACT-IOP-003) Durvalumab and Oleclumab in Resectable PDAC NCT06060405Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Durvalumab, Oleclumab Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas NCT02598349Phase 24 sites📍 Little Rock📍 Jacksonville📍 Warrenville Proton Collaborative Group · Tests: Proton Radiation, Capecitabine, Surgical resection Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery NCT04452461Phase 21 site📍 Hamilton Hamilton Health Sciences Corporation · Tests: mFOLFIRINOX, Gemcitabine / Nab-paclitaxel Pancreatic Cancer Detection Consortium NCT06388967n/a13 sites📍 Phoenix📍 Scottsdale📍 Monrovia City of Hope Medical Center · Tests: PANcreatic cancer Exosome Early detectiON (PANXEON) Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer NCT07645651Phase 11 site📍 Seattle University of Washington · Tests: Samuraciclib, Computed Tomography, Endoscopic Ultrasound Biopsy, Biospecimen Collection Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer NCT06423326Phase 22 sites📍 Washington D.C.📍 Atlanta Georgetown University · Tests: Biopsy, Biospecimen Collection, Cisplatin, Computed Tomography, Gemcitabine Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) NCT07252232Phase 386 sites📍 Birmingham📍 Phoenix📍 Scottsdale Revolution Medicines, Inc. · Tests: daraxonrasib PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer NCT05524090n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Implementation - International best-practice care Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma NCT05083247Phase 210 sites📍 Antwerp📍 Brussels📍 Brussels Erasme University Hospital · Tests: mFOLFIRINOX or Gemcitabine nab-paclitaxel, Isotoxic High-Dose (iHD)-SBRT, Surgery Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma NCT05825066Phase 22 sites📍 Charlotte📍 Winston-Salem Wake Forest University Health Sciences · Tests: Nab paclitaxel, Gemcitabine, Radiological Assessments, mFOLFIRINOX PULSAR in Systemic Therapy for Pancreatic Cancer NCT07269626Phase 21 site📍 Seoul Samsung Medical Center · Tests: Personalized Ultrafractionated Adaptive Radiotherapy Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer NCT05356039n/a1 site📍 Umeå Umeå University 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC NCT07043270Phase 21 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: Nab-paclitaxel + Gemcitabine, modified FOLFIRINOX (mFOLFIRINOX) Targeted Pathway Inhibition in Patients With Pancreatic Cancer NCT04005690EARLY Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Cobimetinib, Olaparib, Onvansertib, Azenosertib, Saruparib Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy NCT07022015NA1 site📍 Minya Minia University · Tests: pancreaticoduodenectomy procedure
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy